An Observational Study to Assess the Real-World Effectiveness of Upadacitinib in Adult Participants With Rheumatoid Arthritis

CompletedOBSERVATIONAL
Enrollment

97

Participants

Timeline

Start Date

March 14, 2022

Primary Completion Date

January 31, 2024

Study Completion Date

January 31, 2024

Conditions
Rheumatoid Arthritis
Trial Locations (15)

LA9 7RG

University Hospitals of Morecambe Bay NHS Foundation Trust /ID# 242376, Kendal

LE1 5WW

Leicester Royal Infirmary /ID# 244674, Leicester

ME7 5NY

Medway NHS Foundation Trust /ID# 244673, Gillingham

SE1 9RT

Guys and St Thomas NHS Foundation Trust /ID# 251704, London

NR4 7UY

Norfolk and Norwich University Hospitals NHS Foundation Trust /ID# 251700, Norwich

NN1 5BD

Northampton General Hospital NHS Trust /ID# 251710, Northampton

BA1 3NG

Royal United Hospitals Bath /ID# 251707, Bath

CB2 0QQ

Cambridge University Hospitals NHS Foundation Trust /ID# 251706, Cambridge

L7 8XP

Liverpool University Hospitals NHS Foundation Trust /ID# 251701, Liverpool

SE5 9RS

King's College Hospital NHS Foundation Trust /ID# 251705, London

BT47 6SB

Western Health and Social Care Trust /ID# 251702, Londonderry

LU4 0DZ

Luton and Dunstable Hospital NHS Foundation Trust /ID# 251699, Luton

NP19 7PH

Aneurin Bevan University Health Board /ID# 251703, Newport

WV10 0QP

The Royal Wolverhampton NHS Trust /ID# 251708, Wolverhampton

YO31 8HE

York and Scarborough Teaching Hospitals NHS Foundation Trust /ID# 244672, York

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY